Stellis Vaccines

VAX-014 · Respiratory syncytial virus in older adults

Phase 2bEnrollingVaccines / Infectious diseaseWatch

Executive summary

Adjuvanted RSV vaccine Ph2b dose-finding. Enrolment on plan, but a manufacturing lot deviation triggered a 6-week pause to re-qualify; recovery plan in place.

Phase

Phase 2b

Stage

Enrolling

Health

Watch

Milestone timeline

Showing completed, in-progress, and at-risk milestones. Planned future milestones are omitted from the sponsor view.

Dec 15, 2024forecast end Dec 11, 2027

FPI
Dec 22, 2024
Complete
25% enrolment
May 8, 2025
Complete
50% enrolment
Oct 21, 2025
Complete
75% enrolment
Apr 15, 2026
In progress

Signed deliverables

Updated live as deliverables are signed.

Essential Documents
filed and signed
Audit Trail
green
CSR draft
not yet released to sponsor

Request an update

Ask for a status update, request a document, or submit a question. The study lead is notified and you’ll see the response in this portal.